Eli Lilly News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

10.12.21	Lilly, Regor Collaborates To Discover & Develop Novel Therapies For Metabolic Disorders (RTTNews)
10.12.21	Lilly and Regor Therapeutics Group Enter into Strategic Collaboration to Discover and Develop Novel Therapies for Metabolic Disorders (PR Newswire)
09.12.21	New Lilly Study Reveals Underappreciation of Bowel Urgency as a Symptom of Ulcerative Colitis and Highlights Communication Gap Between Healthcare Providers and Patients (PR Newswire)
06.12.21	FDA Expands Authorization For Lilly's COVID-19 Antibody Therapy To Include Young Children & Infants (RTTNews)
03.12.21	Lilly's bamlanivimab with etesevimab authorized as the first and only neutralizing antibody therapy for emergency use in COVID-19 patients under the age of 12 (PR Newswire)
01.12.21	Lilly to Announce Initial 2022 Financial Guidance; Provide R&D Overview at Investment Community Meeting (PR Newswire)
29.11.21	Tetra Announces Positive Initial Data From Phase 2 Trials Of QIXLEEF For Cancer Pain (RTTNews)
18.11.21	Emgality® Versus Nurtec® ODT Head-to-Head Migraine Preventive Treatment Study Now Enrolling Patients (PR Newswire)
17.11.21	Lilly to Participate in Fourth Annual Evercore ISI HealthCONx Conference (PR Newswire)
11.11.21	US FDA accepts supplemental New Drug Application and grants Priority Review for Jardiance® for adults with heart failure independent of left ventricular ejection fraction (PR Newswire)
11.11.21	Lilly announces winners of inaugural Leonard Award, a global program celebrating 100 years of innovation in diabetes care (PR Newswire)
09.11.21	Lilly to Participate in Wolfe Research Virtual Healthcare Conference (PR Newswire)
09.11.21	OLUMIANT® Long-Term Safety Profile Established Up to 9.3 Years in Integrated Analysis of More Than 3,700 Patients with Rheumatoid Arthritis (PR Newswire)
05.11.21	Jardiance® shows consistent cardio-renal benefits in adults with heart failure with left ventricular ejection fraction over 40% regardless of chronic kidney disease status (PR Newswire)
04.11.21	Loxo Oncology at Lilly Announces Details of Presentations at the 2021 American Society of Hematology (ASH) Annual Meeting (PR Newswire)
03.11.21	Eli Lilly-Aktie dennoch in Grün: EU-Arzneimittelbehörde stoppt Prüfung von COVID-Medikament von Eli Lilly (AWP) Die EU-Arzneimittelbehörde EMA hat das Prüfverfahren eines COVID-Medikaments des Herstellers Eli Lilly gestoppt.» mehr
02.11.21	Lilly To Supply 614K Additional Doses Of Bamlanivimab And Etesevimab To The US (RTTNews)
02.11.21	Lilly to supply 614,000 additional doses of bamlanivimab and etesevimab to the U.S. Government for the treatment or post-exposure prevention of COVID-19 (PR Newswire)
01.11.21	Lilly to Participate in Bernstein's Second Annual Operational Decisions Conference (PR Newswire)
28.10.21	Additional Verzenio® (abemaciclib) Phase 3 monarchE Trial Data Published in the Annals of Oncology (PR Newswire)
26.10.21	MÄRKTE USA/Überzeugende Berichtssaison sorgt für neue Rekordstände (Dow Jones)
26.10.21	Eli Lilly-Aktie klettert: Eli Lilly kann auch im dritten Quartal deutlich zulegen (AWP) Der US-Pharmakonzern Eli Lilly wächst dank guter Geschäfte etwa mit dem Insulin Trulicity oder dem Schuppenflechtemittel Taltz weiter kräftig.» mehr
26.10.21	MÄRKTE USA/Rekordjagd hält an - Berichtssaison überzeugt weiter (Dow Jones)
26.10.21	MÄRKTE USA/Wall Street startet mit neuen Rekordhochs (Dow Jones)
26.10.21	MÄRKTE USA/Wall Street zum Start mit Aufschlägen erwartet (Dow Jones)
26.10.21	Lilly Lifts FY21 Adj. EPS, Revenue View Above Market - Quick Facts (RTTNews)
26.10.21	Eli Lilly And Co. Profit Drops In Q3 (RTTNews)
26.10.21	Lilly Reports Robust Third-Quarter 2021 Financial Results as Pipeline Success Strengthens Future Growth Potential (PR Newswire)
26.10.21	Ausblick: Eli Lilly and zieht Bilanz zum abgelaufenen Quartal (finanzen.net) So sehen die Prognosen der Experten für die Eli Lilly and-Bilanz aus.» mehr
19.10.21	Lilly : Phase 3 Tirzepatide Results Show Superior A1C And Body Weight Reductions In Type 2 Diabetes (RTTNews)
19.10.21	Tirzepatide results published in The Lancet show superior A1C and body weight reductions compared to insulin glargine in adults with type 2 diabetes with increased cardiovascular risk (PR Newswire)
18.10.21	Lilly Declares Fourth-Quarter 2021 Dividend (PR Newswire)
14.10.21	Lilly Announces Updated Verzenio® (abemaciclib) Phase 3 monarchE Trial Data Presented at ESMO Virtual Plenary and Simultaneously Published in the Annals of Oncology (PR Newswire)
13.10.21	Eli Lilly: FDA Approves Verzenio In Adjuvant Treatment Of HR+ HER2- Early Breast Cancer (RTTNews)
13.10.21	FDA Approves Verzenio® (abemaciclib) as the First and Only CDK4/6 Inhibitor for Certain People with HR+ HER2- High Risk Early Breast Cancer (PR Newswire)
12.10.21	Lilly Confirms Date and Conference Call for Third-Quarter 2021 Financial Results Announcement (PR Newswire)
12.10.21	COVAX Exercises Option To Purchase 176.5 Mln Addl Doses Of Moderna COVID-19 Vaccine In H1 2022 (RTTNews)
11.10.21	Erste Schätzungen: Eli Lilly and präsentiert Quartalsergebnisse (finanzen.net) Eli Lilly and legt die jüngste Bilanz offen. Was Analysten erwarten.» mehr
07.10.21	Loxo Oncology at Lilly Announces Details of Presentations at 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics (PR Newswire)
07.10.21	Sonoco To Implement Price Increase For Uncoated Recycled Paperboard (RTTNews)
04.10.21	Ready for the Challenge? Boehringer Ingelheim and Eli Lilly and Company Launch First Ever Online Game on Cardio-Renal-Metabolic Conditions for Healthcare Professionals (PR Newswire)
01.10.21	At Week 104, 75% of Patients with Ulcerative Colitis Taking Mirikizumab Maintained Symptomatic Remission in Phase 2 Study (PR Newswire)
30.09.21	Lilly, Incyte Present Detailed Results From OLUMIANT BRAVE-AA1, BRAVE-AA2 Trials In Alopecia Areata (RTTNews)
30.09.21	OLUMIANT® Significantly Improved Hair Regrowth to At Least 80% Scalp Coverage as Early as 24 Weeks Across First Completed Phase 3 Studies for Alopecia Areata (PR Newswire)
30.09.21	Lilly Reports Positive Results From Two SURPASS-3 Sub-studies Of Tirzepatide In Type 2 Diabetes (RTTNews)
30.09.21	Lilly's tirzepatide led to greater improvements in liver fat content compared to insulin degludec in adults with type 2 diabetes in SURPASS-3 MRI sub-study (PR Newswire)
30.09.21	Lilly's tirzepatide led to greater time in range compared to insulin degludec in adults with type 2 diabetes in SURPASS-3 CGM sub-study (PR Newswire)
29.09.21	Lilly and Susan G. Komen® Partner to Address Disparities in Breast Cancer Outcomes Experienced By Black Women (PR Newswire)
29.09.21	FDA Expands Lilly's Erbitux Label With Braftovi For Treatment Of Metastatic Colorectal Cancer (RTTNews)
28.09.21	FDA Expands Lilly's ERBITUX® (cetuximab) Label with Combination of BRAFTOVI® (encorafenib) for the Treatment of BRAF V600E Mutation-Positive Metastatic Colorectal Cancer (CRC) after Prior Therapy (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

20.12.24		Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone
20.12.24		Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones
20.12.24		Dow Jones aktuell: Dow Jones notiert am Mittag im Plus
20.12.24		Schwacher Handel: SMI schliesst mit Verlusten
20.12.24		Verluste in Europa: Euro STOXX 50 letztendlich leichter
20.12.24		Schwache Performance in New York: S&P 500 notiert zum Handelsstart im Minus
20.12.24		Börse Frankfurt: So steht der LUS-DAX am Nachmittag
20.12.24		Handel in Zürich: SMI verbucht Verluste

20.12.24

Freundlicher Handel in New York: Dow Jones beendet die Sitzung weit in der Gewinnzone

20.12.24

Handel in New York: Am Freitagnachmittag Gewinne im Dow Jones

20.12.24

Dow Jones aktuell: Dow Jones notiert am Mittag im Plus

20.12.24

Schwacher Handel: SMI schliesst mit Verlusten

20.12.24

Verluste in Europa: Euro STOXX 50 letztendlich leichter

20.12.24

Schwache Performance in New York: S&P 500 notiert zum Handelsstart im Minus